Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by bilosellhion Aug 26, 2004 12:56am
266 Views
Post# 7851640

RE: so mcarter4/bilo had these posts removed

RE: so mcarter4/bilo had these posts removedwhy would i request stockhouse (owned by the same group that operates onc's "frequently" updated website) to remove a post that supports the contentions in my recent posts? what i was critical of was your incredible suggestion that the shorts are vulnerable to BT releasing "real positive" news "unexpectedly soon" imo, your good & valid points lose credibility when you try to spin something that otherwise certainly appears negative into something positive rather than simply letting the facts speak for themselves. if Dr. B Thompson is advising Haywood on biotech stocks and Haywood has been one of the houses selling a lot more onc shares than they've been buying, as you ably pointed out, do you really think the shorts (ie Haywood) are "vulnerable"????? and if Dr.BT is "advising" a fund that has been shorting his own company's stock, aside from an apparent obvious conflict how does that reflect on Dr Brad Thompson? perhaps Matdu, biotexan or other big Dr. Brad Thompson supporters (and bashers of my criticisms of the good Dr.) would care to comment/speculate about this like they do so much on other onc matters, like the science? or is this one of those subjects & posts you prefer to simply defer to others as being outside your area of "expertise"? and its interesting that a lot of those who ridiculed my earlier accusations of censorship of posts by stockhouse like timenhalf & bigwind, Dr. Spock, rangor, harpersbizarre, doubledeuce etc. have been strangely silent about this most recent example. perhaps the good Dr. BT should be more concerned about getting reovirus approved for clincial trials by the FDA than "advising" Haywood or editing posts on stockhouse? comments? matdu? biotexan? proboscis? geoffB?, rjc? any other "respected" and (bilo basher) posters?
Bullboard Posts